NO793759L - Vandig blanding. - Google Patents

Vandig blanding.

Info

Publication number
NO793759L
NO793759L NO793759A NO793759A NO793759L NO 793759 L NO793759 L NO 793759L NO 793759 A NO793759 A NO 793759A NO 793759 A NO793759 A NO 793759A NO 793759 L NO793759 L NO 793759L
Authority
NO
Norway
Prior art keywords
lecithin
water
dihexanoyl
pharmaceutical active
approx
Prior art date
Application number
NO793759A
Other languages
English (en)
Norwegian (no)
Inventor
Dieter Schmidt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO793759L publication Critical patent/NO793759L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO793759A 1978-11-21 1979-11-20 Vandig blanding. NO793759L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1192178 1978-11-21

Publications (1)

Publication Number Publication Date
NO793759L true NO793759L (no) 1980-05-22

Family

ID=4378189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO793759A NO793759L (no) 1978-11-21 1979-11-20 Vandig blanding.

Country Status (22)

Country Link
US (1) US4271196A (OSRAM)
EP (1) EP0011745B1 (OSRAM)
JP (1) JPS5572111A (OSRAM)
KR (1) KR850000584B1 (OSRAM)
AR (1) AR225294A1 (OSRAM)
AT (1) ATE501T1 (OSRAM)
AU (1) AU529061B2 (OSRAM)
CA (1) CA1136988A (OSRAM)
DE (1) DE2961718D1 (OSRAM)
DK (1) DK494079A (OSRAM)
ES (1) ES8101855A1 (OSRAM)
FI (1) FI793461A7 (OSRAM)
GR (1) GR73668B (OSRAM)
HU (1) HU180792B (OSRAM)
IE (1) IE48659B1 (OSRAM)
IL (1) IL58723A (OSRAM)
MC (1) MC1297A1 (OSRAM)
NO (1) NO793759L (OSRAM)
NZ (1) NZ192118A (OSRAM)
PH (1) PH15561A (OSRAM)
PT (1) PT70478A (OSRAM)
ZA (1) ZA796116B (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4457918A (en) * 1982-05-12 1984-07-03 The General Hospital Corporation Glycosides of vitamins A, E and K
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US4891208A (en) * 1985-04-10 1990-01-02 The Liposome Company, Inc. Steroidal liposomes
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
US5231112A (en) 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
DE69637441T2 (de) * 1995-10-17 2009-03-05 Jagotec Ag Verabreichung unlöslicher arzneistoffe
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
ES2201673T3 (es) * 1998-02-11 2004-03-16 Rtp Pharma Corporation Combinacion de esteroides y acidos grasos poiinsaturados para el tratamiento de estados inflamatorios.
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
CA2333648C (en) 1998-05-29 2008-10-21 Rtp Pharma Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
DK1105096T3 (da) 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
HUP0105089A3 (en) 1998-11-20 2002-09-30 Skyepharma Canada Inc Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
CA2383233C (en) * 1999-09-21 2010-06-08 Rtp Pharma Inc. Surface modified particulate compositions of biologically active substances
NZ522239A (en) 2000-04-20 2004-03-26 Skyepharma Canada Inc Improved water-insoluble drug particle process
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
AU2001255515A1 (en) * 2000-09-20 2002-04-02 Skyepharma Canada Inc. Stabilised fibrate microparticles
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
TWI288000B (en) * 2001-02-22 2007-10-11 Rtp Pharma Inc Fibrate-statin combinations with reduced fed-fasted effects
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU29060A1 (OSRAM) *
LU28584A1 (OSRAM) *
FR2102537A5 (OSRAM) * 1970-08-07 1972-04-07 Ugine Kuhlmann
FR2270887A1 (en) * 1974-05-16 1975-12-12 Chabrier De Lassauniere Pierre Prepn of lecithins and glycol-lecithins - by reaction of trimethylamine with 2-substd-2-oxo-1,3,2-dioxaphospholans
SE442014B (sv) * 1976-10-12 1985-11-25 Barry D Sears Syntetisk fosfatidyl-kvarter ammoniumforening till anvendning for solubilisering eller emulgering av vattenolosliga foreningar

Also Published As

Publication number Publication date
US4271196A (en) 1981-06-02
CA1136988A (en) 1982-12-07
AU529061B2 (en) 1983-05-26
NZ192118A (en) 1981-12-15
MC1297A1 (fr) 1980-10-03
EP0011745A1 (de) 1980-06-11
HU180792B (en) 1983-04-29
JPH0122243B2 (OSRAM) 1989-04-25
FI793461A7 (fi) 1981-01-01
DE2961718D1 (en) 1982-02-18
ES486157A0 (es) 1981-01-16
KR850000584B1 (ko) 1985-04-30
GR73668B (OSRAM) 1984-03-28
IE48659B1 (en) 1985-04-03
ATE501T1 (de) 1982-01-15
JPS5572111A (en) 1980-05-30
EP0011745B1 (de) 1981-12-30
IL58723A (en) 1982-11-30
AR225294A1 (es) 1982-03-15
ZA796116B (en) 1980-11-26
DK494079A (da) 1980-05-22
ES8101855A1 (es) 1981-01-16
IE792216L (en) 1980-05-21
IL58723A0 (en) 1980-02-29
AU5282479A (en) 1980-05-29
PT70478A (en) 1979-12-01
PH15561A (en) 1983-02-11

Similar Documents

Publication Publication Date Title
NO793759L (no) Vandig blanding.
DK149483B (da) Fremgangsmaade til fremstilling af vandbaserede injektionsoploesninger indeholdende galdesyrederivater, phosphatider og benzodiazepin
DK175662B1 (da) Blandingsmicelleoplösninger med ikke-steroide inflammationshæmmmere
EP1059941B1 (en) Pharmaceutical compositions and their use
EP1389089B1 (en) Method and composition for solubilising a biologically active compound with low water solubility
US4328222A (en) Pharmaceutical compositions for parenteral or local administration
CN103110579B (zh) 前列地尔注射剂
DK165219B (da) Medikamentholdigt lipidvesikelpraeparat og fremgangsmaade til fremstilling deraf
KR101391020B1 (ko) 수난용성 약제를 함유한 약학 조성물
JP2000319170A (ja) テプレノン含有点眼剤
JPH047722B2 (OSRAM)
FI94835B (fi) Menetelmä 2-fenyyli-1,2-bentsisoselenatsol-3(2H)-onin stabiilien parenteraalisten liuosten valmistamiseksi
US20140329774A1 (en) Injectable composition containing phosphatidylcholine devoid of sodium deoxycholate and preparing method thereof
KR20020063839A (ko) 비경구 투여용 시스플라틴 유탁액
CN101632634B (zh) N(2)-l-丙氨酰-l-谷氨酰胺脂质体注射剂及其制备方法
NO873626L (no) Fremgangsmaate for fremstilling av frysetoerkede farmasoeytiske preparater av fenylkinolinkarboksylsyrer.
JPWO2002053154A1 (ja) エマルション製剤
JPH04505018A (ja) 水性混合ミセル溶液を製造する方法
AU636327B2 (en) Process for the preparation of aqueous mixed micelle solutions
NO150183B (no) Fremgangsmaate ved fremstilling av injeksjonsloesninger
JPH02289511A (ja) 混合ミセル
CN108653204B (zh) 一种多烯磷脂酰胆碱注射液药物组合物及其制备方法
US20220175878A1 (en) Method for preparing eye drops of cyclosporin a
JPH06256212A (ja) オーレオバシジン類のリポソーム製剤
CN101904817A (zh) 一种头孢磺啶钠脂质体注射剂